We are live on ! Find out more
MDSL

M.D. Sass LLC Portfolio holdings

AUM $1.32B
1-Year Est. Return 16.01%
This Fund
S&P 500
This Quarter Est. Return
+2.12%
1 Year Est. Return
+16.01%
3 Year Est. Return
+54.62%
5 Year Est. Return
+70.79%
10 Year Est. Return
+248.43%
AUM
$424M
AUM Growth
-$8.4M
Cap. Flow
-$13.2M
Cap. Flow %
-3.1%
Top 10 Hldgs %
42.34%
Holding
57
New
3
Increased
16
Reduced
32
Closed
4

Top Buys

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$15.8M
2
NXPI icon
NXP Semiconductors
NXPI
+$13M
3
SONY icon
Sony
SONY
+$12.7M
4
CRL icon
Charles River Laboratories
CRL
+$7.24M
5
AMZN icon
Amazon
AMZN
+$1.77M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 28.37%
2 Technology 17.07%
3 Healthcare 11.67%
4 Communication Services 11.53%
5 Financials 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PKG icon
51
Packaging Corp of America
PKG
$22.7B
$690K 0.16%
6,500
-5,103
-44% -$517K
TPHS
52
DELISTED
Trinity Place Holdings Inc.com
TPHS
$486K 0.11%
121,456
+20,456
+20% +$79K
LEN.B icon
53
Lennar Class B
LEN.B
$20B
$309K 0.07%
7,322
+5,260
+255% +$200K
DLTR icon
54
Dollar Tree
DLTR
$23.1B
-18,400
Closed -$1.98M
TER icon
55
Teradyne
TER
$54.8B
-35,000
Closed -$1.68M
GLIBA
56
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
-235,886
Closed -$14.5M
AAWW
57
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
-7,940
Closed -$354K

Similar funds

M.D. Sass LLC's Q3 2019 Portfolio in Review

As of Q3 2019, M.D. Sass LLC held 57 positions worth $424M, down 1.9% from $432M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

M.D. Sass LLC withdrew a net $13.2M in Q3 2019, closing 4 positions and reducing 32 holdings. Its most notable exit was GCI Liberty, Inc. Class A Common Stock (DE), an estimated $14.5M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, down from 30% a quarter earlier, followed by Technology and Healthcare.

Against the trend, M.D. Sass LLC opened a new position in Quest Diagnostics worth $16.5M.

  • M.D. Sass LLC's largest Q3 2019 buy was Quest Diagnostics: 154,057 shares worth $16.5M.
  • M.D. Sass LLC added most to Charles River Laboratories in Q3 2019, an estimated $7.24M increase.
  • M.D. Sass LLC's biggest Q3 2019 reduction was Vulcan Materials, cutting an estimated $10.4M.
  • M.D. Sass LLC fully exited GCI Liberty, Inc. Class A Common Stock (DE) in Q3 2019, selling an estimated $14.5M.
  • M.D. Sass LLC's ten largest holdings make up 42% of its $424M portfolio in Q3 2019.
  • M.D. Sass LLC opened 3 new positions and closed 4 in Q3 2019.
  • M.D. Sass LLC's portfolio value fell 1.9% quarter-over-quarter to $424M.

Based on M.D. Sass LLC's 13F filing for Q3 2019, filed 14 Nov 2019.